Bioengineering market in China luring Korean investors

Published: 2002-09-09 06:58:00

Updated: 2002-09-09 06:58:00

Business sources say that the bio-industry collaboration between China and Korea in the government level will be accelerated amid the growing interests of the domestic pharmaceutical firms and biodrug companies in the Chinese bioengineering market, since China's affiliation with the WTO.

The d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK